BIOMARIN PHARMACEUTICAL INC. Patent Application Trends in 2025
Revision as of 05:08, 28 March 2025 by Wikipatents (talk | contribs) (Updating BIOMARIN PHARMACEUTICAL INC._Patent_Application_Trends_in_2025)
Contents
BIOMARIN PHARMACEUTICAL INC. Patent Filing Activity
BIOMARIN PHARMACEUTICAL INC. patent applications in 2025
Top 10 Technology Areas
- A61K38/17 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 1 patents
- Example: 20250032576. CNP Therapy (BIOMARIN PHARMACEUTICAL INC.)
- A61P19/08 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
- Count: 1 patents
- Example: 20250032576. CNP Therapy (BIOMARIN PHARMACEUTICAL INC.)
- C07K14/435 (from animals; from humans)
- Count: 1 patents
- Example: 20250032576. CNP Therapy (BIOMARIN PHARMACEUTICAL INC.)
- G01N33/573 (for enzymes or isoenzymes)
- Count: 1 patents
- Example: 20250032576. CNP Therapy (BIOMARIN PHARMACEUTICAL INC.)
- G01N33/6893 ({related to diseases not provided for elsewhere})
- Count: 1 patents
- Example: 20250032576. CNP Therapy (BIOMARIN PHARMACEUTICAL INC.)
- G01N2800/52 (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing processes other than immunoassay, involving enzymes or microorganisms)
- Count: 1 patents
- Example: 20250032576. CNP Therapy (BIOMARIN PHARMACEUTICAL INC.)
- C12N7/00 (Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines,)
- Count: 1 patents
- Example: 20250084383. LARGE SCALE ADENO-ASSOCIATED VIRUS PRODUCTION SYSTEMS (BIOMARIN PHARMACEUTICAL INC.)
- C12N5/0601 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- Count: 1 patents
- Example: 20250084383. LARGE SCALE ADENO-ASSOCIATED VIRUS PRODUCTION SYSTEMS (BIOMARIN PHARMACEUTICAL INC.)
- C12N2710/14022 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- Count: 1 patents
- Example: 20250084383. LARGE SCALE ADENO-ASSOCIATED VIRUS PRODUCTION SYSTEMS (BIOMARIN PHARMACEUTICAL INC.)
- C12N2710/14044 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- Count: 1 patents
- Example: 20250084383. LARGE SCALE ADENO-ASSOCIATED VIRUS PRODUCTION SYSTEMS (BIOMARIN PHARMACEUTICAL INC.)
Emerging Technology Areas
- C12N2750/14152 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- Count: 1 patents
- Example: 20250084383. LARGE SCALE ADENO-ASSOCIATED VIRUS PRODUCTION SYSTEMS (BIOMARIN PHARMACEUTICAL INC.)
- C12N2750/14143 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- Count: 1 patents
- Example: 20250084383. LARGE SCALE ADENO-ASSOCIATED VIRUS PRODUCTION SYSTEMS (BIOMARIN PHARMACEUTICAL INC.)
- C12N2710/14044 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- Count: 1 patents
- Example: 20250084383. LARGE SCALE ADENO-ASSOCIATED VIRUS PRODUCTION SYSTEMS (BIOMARIN PHARMACEUTICAL INC.)
- C12N2710/14022 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- Count: 1 patents
- Example: 20250084383. LARGE SCALE ADENO-ASSOCIATED VIRUS PRODUCTION SYSTEMS (BIOMARIN PHARMACEUTICAL INC.)
- C12N5/0601 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- Count: 1 patents
- Example: 20250084383. LARGE SCALE ADENO-ASSOCIATED VIRUS PRODUCTION SYSTEMS (BIOMARIN PHARMACEUTICAL INC.)
- C12N7/00 (Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines,)
- Count: 1 patents
- Example: 20250084383. LARGE SCALE ADENO-ASSOCIATED VIRUS PRODUCTION SYSTEMS (BIOMARIN PHARMACEUTICAL INC.)
- G01N2800/52 (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing processes other than immunoassay, involving enzymes or microorganisms)
- Count: 1 patents
- Example: 20250032576. CNP Therapy (BIOMARIN PHARMACEUTICAL INC.)
- G01N33/6893 ({related to diseases not provided for elsewhere})
- Count: 1 patents
- Example: 20250032576. CNP Therapy (BIOMARIN PHARMACEUTICAL INC.)
- G01N33/573 (for enzymes or isoenzymes)
- Count: 1 patents
- Example: 20250032576. CNP Therapy (BIOMARIN PHARMACEUTICAL INC.)
- C07K14/435 (from animals; from humans)
- Count: 1 patents
- Example: 20250032576. CNP Therapy (BIOMARIN PHARMACEUTICAL INC.)
Top Inventors
- George Jeha of Novato CA (US) (1 patent)
- Christopher Bauer of Oakland CA (US) (1 patent)
- Sergio Covarrubias of Novato CA (US) (1 patent)
- Devanshi Shanghavi of Novato CA (US) (1 patent)
- Yu-Shan Tseng of Novato CA (US) (1 patent)
- Jonathan Day (1 patent)
- Elena Fisheleva of Novato CA (US) (1 patent)
- Tomas CINEK of Novato CA (US) (1 patent)
- Joseph Charles PELTIER of Novato CA (US) (1 patent)
- Juan Jose APONTE-UBILLUS of Novato CA (US) (1 patent)